跳至主要内容
临床试验/NCT06318598
NCT06318598招募中不适用

Dissezione Fenotipica Guidata da Biomarcatori Della Sclerosi Laterale Amiotrofica/Biomarker-driven Phenotypic Dissection of Amyotrophic Lateral Sclerosis

Istituto Auxologico Italiano3 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2023年4月11日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200
试验地点
3
主要终点
biomarker assessment

研究概览

简要总结

The goal of this observational study is to understand the clinical variability in a population of ALS patients using multidimensional biomarkers. The main questions it aims to answer are:

  • Which set of biomarkers explain genotypic-phenotypic correlations in ALS?
  • Which set of biomarkers can be used to subdivide the ALS population in homogeneous subgroups?

Participants will undergo:

  • neurological evaluation
  • neurophysiological evaluation
  • neuropsychological evaluation
  • whole exome sequencing
  • biomarker measurement in CSF and plasma

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • diagnosis of ALS or other motor neuron disease
  • residence near the study centers

排除标准

  • refusal to participate to the study
  • unable/unwilling to perform follow-up visits

结局指标

主要结局

biomarker assessment

时间窗: baseline (at diagnosis), at 6 months, at 1 year

no. of patients with abnormal NfL, GFAP, tau, UCHL1, MCP1 and TDP-43 levels

genetic screening

时间窗: baseline (at diagnosis)

no. of patients with ALS-associated mutations

次要结局

  • neuropsychological assessment(baseline (at diagnosis), at 1 year)
  • clinical assessment(baseline (at diagnosis), at 6 months, at 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验

Biomarker-driven Phenotypic Dissection of... | 临床试验